Kiniksa Pharmaceuticals International, Plc

Contributing Author

Recent Articles by Kiniksa Pharmaceuticals International, Plc

Feb-25	Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference KNSA GlobeNewswire
Feb-24	Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution KNSA -8.21% GlobeNewswire
Feb-19	Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 KNSA GlobeNewswire
Jan-12	Kiniksa Pharmaceuticals Provides Corporate Update KNSA GlobeNewswire
Jan-07	Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference KNSA GlobeNewswire
Nov-12	Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London KNSA GlobeNewswire
Oct-28	Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution KNSA GlobeNewswire
Oct-23	Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025 KNSA GlobeNewswire
Oct-17	Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis KNSA GlobeNewswire
Aug-28	Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences KNSA GlobeNewswire
Jul-29	Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution KNSA +12.32% GlobeNewswire
Jul-24	Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 KNSA GlobeNewswire